November 30, 2010

The spate of recent product recalls may be eroding consumer confidence in the Food and Drug Administration, according to a PricewaterhouseCoopers survey of 1,000 Americans released Tuesday.

November 30, 2010

Ranbaxy Pharmaceuticals has received final approval for its generic Alzheimer's drug from the Food and Drug Administration, giving the drug maker 180 days of market exclusivity.

November 30, 2010

Recent public perception that the Food and Drug Administration had not been doing its job — ensuring that Americans' approved medical devices and medicines are relatively safe — may be impeding fast approval processes, according to a new PricewaterhouseCoopers report published Tuesday.

November 29, 2010

The Food and Drug Administration has extended its review period for a multiple sclerosis drug made by EMD Serono, the drug maker said Friday.

November 29, 2010

Generic drug maker Impax Labs is challenging the patent covering a drug used to treat high cholesterol, the company said Friday.

November 24, 2010

Most of the newly elected and re-elected Republican members of Congress, Tea Party candidates in particular, vowed to whittle down or repeal healthcare reform once in office, but the healthcare companies that stand to benefit hope to change their minds, as some of their lobbying activities last quarter have shown.

November 22, 2010

A generic drug maker has entered an agreement to purchase another drug maker's U.S. penicillin site ...

November 22, 2010

WOODCLIFF LAKE, N.J. Par Pharmaceutical has begun shipments of a generic treatment for asthma, the drug maker said Monday.

Par announced that it started shipping zafirlukast tablets in the 10-mg and 20-mg strengths. The drug is a generic version of AstraZeneca’s Accolate.

Accolate has sales of $50 million in the United States per year, according to IMS Health.

November 22, 2010

The pharmaceutical lobby spent more than $5 million lobbying the government during the third quarter ...

November 21, 2010

Pfizer has extended the deadline of its $3.6 billion offer to buy King Pharmaceuticals, Pfizer...

November 21, 2010

Indian generic drug maker Dr. Reddy’s Labs has launched a version of an asthma drug...

November 21, 2010

A drug maker will pull a common prescription painkiller from the market following the release...

November 18, 2010

Johnson & Johnson and the U.S. government are suing two generic drug makers to stop...

November 17, 2010

Swiss drug maker Novartis will focus on innovation as part of a program for long-term...

November 16, 2010

With the holiday season just around the corner, CVS/pharmacy is encouraging older adults and their...

November 15, 2010

The U.S. District Court for the District of Delaware has upheld a patent held by...

November 15, 2010

The Food and Drug Administration has approved a generic treatment made by Impax for seasonal...

November 15, 2010

Generic drug maker Actavis has filed for approval of a generic version of an antidepressant...

November 15, 2010

The Food and Drug Administration has granted orphan drug designation to a drug for treating...

November 15, 2010

A social media go-to-market strategy is fast becoming a must-have for companies these days, especially...

November 14, 2010

William Gibson, the science-fiction author who helped create the cyberpunk genre in the 1980s and...

November 14, 2010

The world of generic drugs has a big year ahead of it. Actually, it has...

November 14, 2010

A backlog of more than 2,000 drug entities and devices is awaiting approval. That’s the...

November 14, 2010

A ghost from 2008 soon could come back to haunt 2010....